M. Mani Chandana*, Tagore Tanniru, Erothi Balakoti, Routhu Pratyusha, K. Eswar Kumar, B. Lakshman

PIMAVANSERIN (NUPLAZID): A SELECTIVE 5-HT2A INVERSE AGONIST FOR PARKINSON'S DISEASE PSYCHOSIS

Psychosis is among the most disabling non-motor complications of Parkinson’s disease (PD), affecting up to 60% of patients over the course of illness and increasing the risks of institutionalisation and death. Treatment has long been constrained by the dopamine D2-receptor antago...